CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03403283
NCT03403283N/ACompleted
CompareCT.gov

Dyslipidemia and Diabetic Retinopathy

University of Alabama at Birmingham·observational·Posted Jan 18, 2018·Updated May 21, 2024

In Brief

An observational study evaluating 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy and Healthy Controls 15 age matched control subjects for Diabetic Retinopathy and Dyslipidemia. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Retinopathy, Dyslipidemia
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 18, 2018
Enrollment StartJan 1, 2014
Primary CompletionApr 30, 2023
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 8.5 years ago

Interventions

15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathyother

Healthy Controls 15 age matched control subjectsother